NO20052487D0 - 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater. - Google Patents

1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.

Info

Publication number: NO20052487D0
Authority: NO; Norway
Prior art keywords: propenone; piperazin; benzyl; phenyl
Prior art date: 2002-10-25

Application number

NO20052487A

Other languages

English (en)

Other versions

NO20052487L (no

Inventor

Rudolf Waelchli

Laszlo Revesz

Richard Heng

Achim Schlapbach

Birgit Bollbuck

Jorg Eder

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-25

Filing date

2005-05-24

Publication date

2005-05-24

2005-05-24 Application filed by Novartis Ag filed Critical Novartis Ag

2005-05-24 Publication of NO20052487D0 publication Critical patent/NO20052487D0/no

2005-05-24 Publication of NO20052487L publication Critical patent/NO20052487L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20052487A 2002-10-25 2005-05-24 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater. NO20052487L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0224917.5A GB0224917D0 (en)	2002-10-25	2002-10-25	Organic compounds
PCT/EP2003/011848 WO2004037796A2 (en)	2002-10-25	2003-10-24	1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives

Publications (2)

Publication Number	Publication Date
NO20052487D0 true NO20052487D0 (no)	2005-05-24
NO20052487L NO20052487L (no)	2005-05-24

Family

ID=9946616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052487A NO20052487L (no)	2002-10-25	2005-05-24	1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.

Country Status (19)

Country	Link
US (1)	US7645760B2 (no)
EP (1)	EP1558594A2 (no)
JP (1)	JP2006505575A (no)
KR (1)	KR20050065620A (no)
CN (2)	CN100554257C (no)
AR (1)	AR043055A1 (no)
AU (1)	AU2003296559B2 (no)
BR (1)	BR0315662A (no)
CA (1)	CA2502633C (no)
EC (1)	ECSP055745A (no)
GB (1)	GB0224917D0 (no)
MX (1)	MXPA05004348A (no)
NO (1)	NO20052487L (no)
PE (1)	PE20040779A1 (no)
PL (1)	PL374893A1 (no)
RU (1)	RU2347782C2 (no)
TW (1)	TW200420545A (no)
WO (1)	WO2004037796A2 (no)
ZA (1)	ZA200502700B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7456184B2 (en) *	2003-05-01	2008-11-25	Palatin Technologies Inc.	Melanocortin receptor-specific compounds
SE0400440D0 (sv) *	2004-02-25	2004-02-25	Active Biotech Ab	Novel Cinnamic Amides
SE0400441D0 (sv)	2004-02-25	2004-02-25	Active Biotech Ab	Novel Benzofurans and Indols
GB0409236D0 (en) *	2004-04-26	2004-05-26	Novartis Ag	Organic compounds
US7777035B2 (en)	2005-06-22	2010-08-17	Chemocentryx, Inc.	Azaindazole compounds and methods of use
CN101007794B (zh) *	2006-01-26	2010-09-01	中国科学院上海药物研究所	N,n'-二取代哌嗪类衍生物及其制备方法、药物组合物和用途
US7601844B2 (en)	2006-01-27	2009-10-13	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
US7615556B2 (en)	2006-01-27	2009-11-10	Bristol-Myers Squibb Company	Piperazinyl derivatives as modulators of chemokine receptor activity
WO2008090357A2 (en) *	2007-01-24	2008-07-31	Palatin Technologies, Inc.	N, n; -substituted piperazines binding to melanocortin receptor
TWI433838B (zh)	2008-06-25	2014-04-11	必治妥美雅史谷比公司	作為趨化因子受體活性調節劑之六氫吡啶衍生物
DK2528897T3 (en) *	2010-01-29	2014-12-08	Otsuka Pharma Co Ltd	DI-substituted pyridine derivatives as anticancer agents
US8642622B2 (en)	2010-06-16	2014-02-04	Bristol-Myers Squibb Company	Piperidinyl compound as a modulator of chemokine receptor activity
EP2883870B8 (en)	2012-08-08	2019-01-23	Mitsubishi Tanabe Pharma Corporation	Method for producing 1,4-benzoxazine compound
EP2938347A4 (en) *	2012-12-30	2016-08-10	Hadasit Med Res Service	USE OF ALGINATE COMPOSITIONS TO PREVENT OR PREVENT LIVER DAMAGE THROUGH HEPATOTOXIC
BR112016000779A8 (pt)	2013-07-18	2020-01-07	Novartis Ag	inibidores de autotaxina que compreendem núcleo do ciclo de benzilamida de anel heteroaromático, seus usos, composição e combinação farmacêuticas
US9776979B2 (en) *	2013-09-26	2017-10-03	Sanford-Burnham Medical Research Institute	EBI2 modulators
AU2016209906A1 (en) *	2015-01-20	2017-08-03	Novartis Ag	PET imaging agents
WO2021102359A2 (en) *	2019-11-22	2021-05-27	The Regents Of The University Of California	Taspase1 inhibitors and uses thereof
EP4065570A1 (en)	2019-11-28	2022-10-05	Bayer Aktiengesellschaft	Substituted aminoquinolones as dgkalpha inhibitors for immune activation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60139646A (ja) *	1983-12-27	1985-07-24	Otsuka Pharmaceut Factory Inc	ナフタレン誘導体
JPS6219577A (ja) *	1985-07-16	1987-01-28	Kanebo Ltd	新規なベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物
US5380726A (en) *	1993-01-15	1995-01-10	Ciba-Geigy Corporation	Substituted dialkylthio ethers
FR2725445B1 (fr) *	1994-10-10	1996-10-31	Adir	Nouveaux derives a structure 1-arylalkenyl 4-aryl alkyl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2000086603A (ja)	1998-07-15	2000-03-28	Yoshitomi Pharmaceut Ind Ltd	桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体
US6110922A (en) *	1998-12-29	2000-08-29	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
EA006243B1 (ru) *	2001-10-22	2005-10-27	Пфайзер Продактс Инк.	Производные пиперазина с антагонистической активностью к рецептору ccr1

2002
- 2002-10-25 GB GBGB0224917.5A patent/GB0224917D0/en not_active Ceased
2003
- 2003-10-21 TW TW092129162A patent/TW200420545A/zh unknown
- 2003-10-23 AR ARP030103870A patent/AR043055A1/es not_active Application Discontinuation
- 2003-10-23 PE PE2003001076A patent/PE20040779A1/es not_active Application Discontinuation
- 2003-10-24 US US10/532,331 patent/US7645760B2/en not_active Expired - Fee Related
- 2003-10-24 BR BR0315662-1A patent/BR0315662A/pt not_active IP Right Cessation
- 2003-10-24 KR KR1020057006954A patent/KR20050065620A/ko active IP Right Grant
- 2003-10-24 CN CNB2003801020110A patent/CN100554257C/zh not_active Expired - Fee Related
- 2003-10-24 JP JP2004545990A patent/JP2006505575A/ja active Pending
- 2003-10-24 MX MXPA05004348A patent/MXPA05004348A/es active IP Right Grant
- 2003-10-24 PL PL03374893A patent/PL374893A1/xx not_active Application Discontinuation
- 2003-10-24 EP EP03809328A patent/EP1558594A2/en not_active Withdrawn
- 2003-10-24 WO PCT/EP2003/011848 patent/WO2004037796A2/en active Application Filing
- 2003-10-24 RU RU2005115964/04A patent/RU2347782C2/ru not_active IP Right Cessation
- 2003-10-24 CA CA2502633A patent/CA2502633C/en not_active Expired - Fee Related
- 2003-10-24 CN CNA2009101474324A patent/CN101570517A/zh active Pending
- 2003-10-24 AU AU2003296559A patent/AU2003296559B2/en not_active Ceased
2005
- 2005-04-04 ZA ZA200502700A patent/ZA200502700B/en unknown
- 2005-04-25 EC EC2005005745A patent/ECSP055745A/es unknown
- 2005-05-24 NO NO20052487A patent/NO20052487L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003296559A1 (en)	2004-05-13
EP1558594A2 (en)	2005-08-03
KR20050065620A (ko)	2005-06-29
WO2004037796A2 (en)	2004-05-06
RU2347782C2 (ru)	2009-02-27
WO2004037796A3 (en)	2004-06-17
PL374893A1 (en)	2005-11-14
US7645760B2 (en)	2010-01-12
JP2006505575A (ja)	2006-02-16
ZA200502700B (en)	2006-05-31
BR0315662A (pt)	2005-08-30
CA2502633C (en)	2011-02-01
CN100554257C (zh)	2009-10-28
CN1708489A (zh)	2005-12-14
CN101570517A (zh)	2009-11-04
CA2502633A1 (en)	2004-05-06
AU2003296559B2 (en)	2007-11-01
PE20040779A1 (es)	2004-12-21
RU2005115964A (ru)	2006-01-27
ECSP055745A (es)	2005-07-06
NO20052487L (no)	2005-05-24
AR043055A1 (es)	2005-07-13
TW200420545A (en)	2004-10-16
US20060173004A1 (en)	2006-08-03
GB0224917D0 (en)	2002-12-04
MXPA05004348A (es)	2005-08-02

Publication	Publication Date	Title
NO20053248D0 (no)	2005-07-01	Kerosenblanding.
NO20052487D0 (no)	2005-05-24	1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
NO20052248D0 (no)	2005-05-09	Svivelstykkesystem.
ITMI20032170A1 (it)	2004-06-22	Tagliacimosse.
NO20051497D0 (no)	2005-03-21	Beta-laktamaseinhibitorprodrug.
ITMI20030916A1 (it)	2003-11-23	Lancetta.
ES1051856Y (es)	2003-02-01	Burlete perfeccionado.
ES1052590Y (es)	2003-05-01	Quiosco-consigna.
ES1051038Y (es)	2002-10-16	Sofa perfeccionado.
ES1050965Y (es)	2002-10-01	Decantador perfeccionado.
ES1051803Y (es)	2003-02-01	Andamio perfeccionado.
ES1052938Y (es)	2003-06-16	Cantonera.
ES1052945Y (es)	2003-06-16	Contraventana.
ES1052011Y (es)	2003-03-01	Espetero.
ES1051703Y (es)	2003-01-16	Potera.
ES1052029Y (es)	2003-03-01	Balin-proyectil.
ES1052654Y (es)	2003-05-01	Cubitera.
ES1052024Y (es)	2003-03-01	Jamonero.
ES1052566Y (es)	2003-05-01	Jamonero.
ITVE20020013U1 (it)	2003-10-29	Bloccalaccio.
ITCH20020016A1 (it)	2004-06-07	Videospecchi.
ITRE20020089A1 (it)	2004-05-13	Apparecchiatutto.
ITTO20020722A1 (it)	2004-02-14	Alchinilcarbossi-nucleotidi.
ITVI20020277A1 (it)	2004-06-21	Salvapenne.
ITRM20020327A0 (it)	2002-06-10	Dnaser.

Legal Events

Date	Code	Title	Description
2008-05-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application